Tirzepatide Prescribing at WOODSTOCK BOWER GROUP PRACTICE
Drugs used in diabetes | Endocrine System
Items (12m)
855
Total Quantity
885
NHS Cost
£88.6K
vs National Avg
+340.2%
WOODSTOCK BOWER GROUP PRACTICE prescribed 855 items of Tirzepatide over the last 12 months at a cost of £88,625 to the NHS. This is 340.2% above the national average prescribing rate. Tirzepatide is classified under Drugs used in diabetes in the BNF.
Monthly Prescribing Trend
Jul 2026
24
Jul 2026
52
Jul 2026
66
Jul 2026
64
Jul 2026
86
Jul 2026
86
Jul 2026
73
Jul 2026
72
Jul 2026
82
Jul 2026
69
Jul 2026
89
Jul 2026
92
Prescribing Details
| Total Items | 855 |
|---|---|
| Total Quantity | 885 |
| Total NHS Cost | £88,625 |
| Presentations | 10 different forms |
| vs National Average | +340.2% |
Tirzepatide Prescribing Comparison
| This practice | 855 items |
|---|---|
| National average per practice | 194 items |
| Difference | +340.2% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.